Related Experiment Videos
[Clinical trial of domestic drug polyoxidonium in secondary immunodeficiency]
Aim:
To test clinical efficiency and immunocorrectives characteristics of polyoxidonium in patients with chronic bronchitis (CB) and chronic recurrent furunculosis.
Materials And Methods:
56 patients entered the trial; 13 with CB in remission, 22 with CB in exacerbation and 21 with chronic recurrent furunculosis. Clinical examinations and tests were made before polyoxidonium therapy and 2-3 days after it. Immunological tests consisted of determination of sub-population composition of peripheral blood lymphocytes, serum immunoglobulins and phagocytic activity of neutrophils.
Results:
Polyoxidonium is an effective and safe immunocorrector. It has a strong influence on functional activity of blood phagocytic cells.
Conclusion:
Polyoxidonium treatment of CB and chronic recurrent furunculosis results in positive shifts in hematological and immunological indices. This allows to recommend it for treatment of acute and chronic infections.